Kennedy E - Search Results

1

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.

Neogi U, Elaldi N, Appelberg S, Ambikan A, Kennedy E, Dowall S, Bagci BK, Gupta S, Rodriguez JE, Svensson-Akusjärvi S, Monteil V, Vegvari A, Benfeitas R, Banerjea A, Weber F, Hewson R, Mirazimi A. Neogi U, et al. Among authors: kennedy e. Elife. 2022 Apr 19;11:e76071. doi: 10.7554/eLife.76071. Elife. 2022. PMID: 35437144 Free PMC article.

2

A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model.

Kennedy EM, Dowall SD, Salguero FJ, Yeates P, Aram M, Hewson R. Kennedy EM, et al. Vaccine. 2019 Aug 23;37(36):5404-5413. doi: 10.1016/j.vaccine.2019.07.023. Epub 2019 Jul 19. Vaccine. 2019. PMID: 31331770 Free article.

3

Development of humanised antibodies for Crimean-Congo Haemorrhagic fever virus: Comparison of hybridoma-based versus phage library techniques.

Dowall SD, Graves LP, Kennedy E, Graham VA, Alakeely RA, Chambers A, Possee RD, King LA, Hewson R. Dowall SD, et al. Among authors: kennedy e. J Immunol Methods. 2023 Jan;512:113405. doi: 10.1016/j.jim.2022.113405. Epub 2022 Dec 7. J Immunol Methods. 2023. PMID: 36496007 Free article.

4

Investigating the effect of ribavirin treatment on genetic mutations in Crimean-Congo haemorrhagic fever virus (CCHFV) through next-generation sequencing.

D'Addiego J, Elaldi N, Wand N, Osman K, Bagci BK, Kennedy E, Pektas AN, Hart E, Slack G, Hewson R. D'Addiego J, et al. Among authors: kennedy e. J Med Virol. 2023 Feb;95(2):e28548. doi: 10.1002/jmv.28548. J Med Virol. 2023. PMID: 36734067

5

Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model.

Saunders JE, Gilbride C, Dowall S, Morris S, Ulaszewska M, Spencer AJ, Rayner E, Graham VA, Kennedy E, Thomas K, Hewson R, Gilbert SC, Belij-Rammerstorfer S, Lambe T. Saunders JE, et al. Among authors: kennedy e. EBioMedicine. 2023 Apr;90:104523. doi: 10.1016/j.ebiom.2023.104523. Epub 2023 Mar 17. EBioMedicine. 2023. PMID: 36933409 Free PMC article.

6

Pathogenesis of Rift Valley Fever Virus in a BALB/c Mouse Model Is Affected by Virus Culture Conditions and Sex of the Animals.

Graham VA, Easterbrook L, Kennedy E, Rayner E, Findlay-Wilson S, Flett L, Wise EL, Treagus S, Fotheringham S, Kempster S, Almond N, Dowall S. Graham VA, et al. Among authors: kennedy e. Viruses. 2023 Nov 30;15(12):2369. doi: 10.3390/v15122369. Viruses. 2023. PMID: 38140610 Free PMC article.

7

Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.

Kempster S, Hassall M, Graham V, Kennedy E, Findlay-Wilson S, Salguero FJ, Bagci B, Elaldi N, Oz M, Tasseten T, Charlton FW, Barr JN, Fontana J, Duru C, Ezeajughi E, Matejtschuk P, Arnold U, Adedeji Y, Mirazimi A, Hewson R, Dowall S, Almond N. Kempster S, et al. Among authors: kennedy e. Virus Res. 2024 Aug;346:199409. doi: 10.1016/j.virusres.2024.199409. Epub 2024 Jun 1. Virus Res. 2024. PMID: 38815869 Free PMC article.

8

A Review of Nonhuman Primate Models of Rift Valley Fever Virus Infection: Progress, Challenge Strains, and Future Directions.

Ebisine K, Quist D, Findlay-Wilson S, Kennedy E, Dowall S. Ebisine K, et al. Among authors: kennedy e. Pathogens. 2024 Oct 1;13(10):856. doi: 10.3390/pathogens13100856. Pathogens. 2024. PMID: 39452727 Free PMC article. Review.

9

Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains.

Graham VA, Easterbrook L, Rayner E, Findlay-Wilson S, Flett L, Kennedy E, Fotheringham S, Kempster S, Almond N, Dowall S. Graham VA, et al. Among authors: kennedy e. Viruses. 2024 Sep 27;16(10):1534. doi: 10.3390/v16101534. Viruses. 2024. PMID: 39459867 Free PMC article.

10

Recombinant Vaccine Production: Production of a Recombinant CCHF MVA Vaccine.

Kennedy E, Hewson R, Dowall S. Kennedy E, et al. Methods Mol Biol. 2025;2893:257-272. doi: 10.1007/978-1-0716-4338-9_19. Methods Mol Biol. 2025. PMID: 39671043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,815 results

Search Page

Filters